CEV — Centrotec SE Balance Sheet
0.000.00%
FinancialsAdventurousMid Cap
- €827.07m
- €917.13m
- €323.74m
Annual balance sheet for Centrotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 152 | 122 | 190 | 71.5 | 602 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 71.5 | 79.1 | 94.8 | 34.7 | 40.5 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 307 | 292 | 435 | 653 | 723 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 130 | 159 | 195 | 120 | 121 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 568 | 588 | 827 | 910 | 1,291 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 112 | 119 | 181 | 391 | 186 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 329 | 358 | 532 | 568 | 270 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 240 | 230 | 295 | 342 | 1,021 |
Total Liabilities & Shareholders' Equity | 568 | 588 | 827 | 910 | 1,291 |
Total Common Shares Outstanding |